Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He Will sell out 2,8 million shares seems... I m loading undervalued 0.01
my take AS increase and since shres being converted at 0086
Not sure bud
is this in phase 1?
don t think dillution anyway bc insider have bought shares... per fillings
Yep it does. The other day the bid/ask spread was large @ .0131/.0173 eod if I recall correctly. Today good for filling bids. Just added a few more
CTBO $$$
Today feels like institutional dumping
locked and loaded waiting for buy out. MY ownerships 1,394000 shares and more will add looking for big industrial player buy out .... PPS MORE THAN dollar land easy .... if looking latest 8 k company have still strong credibility ENJOY AND ... :::)))))
shares being convered at 0086
REMEMBER FREAK PPC* WELL THIS CAN DO IT ONE DAY WITH LESS FLOAT, IM A BUYER AFTER MY MJ PLAY
Nothing is going through at the bid today
Bid whacker central here , must pay have his profit to comission fees
Noticed that. Got a partial fill on a bid not for many shares, wish it went through entirely lol. Still loaded though
CTBO $$$
Bids and asks moving up steadily
Also new company director: http://ih.advfn.com/p.php?pid=nmona&article=78462610
On October 12, 2018, our board of directors appointed Dr. Max Zhu as a director of our company.
Dr. Max Zhu, age 36, has been a research scientist and Head of Computer-Aided Drug Design at Cantabio Pharmaceuticals Inc. since 2015. His areas of responsibility expanded in late 2017 to include business development activities for the company in Asia. Dr. Zhu has been a key player in the advancement of Cantabio’s therapeutic programs. More recently he has become more involved in developing business and investor relationships for the company in Asia, where he is able to bring his network of contacts both in research and the investment community to help with the commercial development of the company. Prior to working with Cantabio, Dr. Zhu has worked as a scientist at VITA-Genes and also as Technology Officer at Vitargent Biotechnologies, both biotech companies based in the Hong Kong Science Park. In these roles he developed knowledge and knowhow in biomedical innovations and R&D commercialization in the region. At both companies he was also involved in business development and strategies as well as sales and marketing, gaining experiences as a biotech entrepreneur in the greater China area.
Dr. Zhu obtained his PhD at the University of Cambridge researching Alzheimer’s Disease in 2013. His thesis focused on computational studies of the Abeta peptide and amyloid which led to the discovery of a set of compounds which could become potential drug leads for Alzheimer’s disease. Dr. Zhu’s research required the use of computer science, AI, genome and protein structure analysis, computational biology and chemistry, applying the combination of different skillsets and knowledge in a multi-disciplinary biomedical research environment, and he has been both lead and co-author on a number of peer reviewed articles in this area.
Dr. Zhu has entered into convertible loan agreements with Cantabio as previously disclosed with the SEC.
CTBO $$$
8K is out. Increased OS by 20 million
Insiders own roughly 39 million shares per the filings just released
Bid= flipper reload
Pretty big bid building. The mms have controlled this. They would be pummeled if the company would release better news than just presenting their concept. We as investors need more than that.
Was watching this but it seems its someones 2 tick flip toy glta-
So you own 3.5% of the float
INTRESTING FUTURE CHECK
https://www.cantabio.com/scientific-approach/pipeline
How did .035 print here today?
CTBO $$$
OUUR CEO GET 2 GRANT FROM MICHAEL J FOX FOUNDATION...LINK UNDER
https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=1252
https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=771
without funding they cannot take it to clinical trials…. that s the fact
as i ll read last pr seems that CANTABIO trying to sell their Program to some big industrial player who can take it to clinical trials and CANTABIO will get one time payment and future milestone bonus from revenue …
or ?????????
Lots of good articles there. This one?
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licenses-tau-protein-targeting-therapeutic-programme/
CTBO $$$
I feel retail investors have been shut out of this shakedown over the last couple days. I’ve put bid numerous times only to be denied for a lower offer
NICE OLD ARTICLE :https://search.cam.ac.uk/web?query=CANTABIO
WONDERING AS , WHEN CTBO WILL RELEASE SOME GOOD PR... ..???,,, SHORT SELLING ALLMOST MAXIMIUM , WHERE ARE THE BOTTOM ???
NEED S SOME STRONG PR TO KICK OF PPS SOMEKIND OF CONCRETE PR... COMPANYS FUTURE.... ???? I M NOT WORRYED COMPANY SEEMS STRONG AND RESPECTFULLY WITH OTHER....
Always those bastards
MMs doing their thing?
CTBO $$$
This is not real. My bid was 30% higher than a trade that went through for the same number of shares and I didn’t get filled
I picked up more. I saw CDEL had 250k to get rid of the last couple days
Somebody's getting out. Bargain price now
CTBO $$$
They have been presenting their protein targeting concept all over the world. They will be bought out by someone I’d think. If their product was no good, they wouldn’t be invited to present at all of these conferences.
This stock is going to be a monster. Over half of the OS is restricted...the 20mil float has been slowly accumulated. No free trading shares left....only one direction when this happens...$$$$$
All they need is a seat at the table and one of them to believe or expand upon their research and watch out!
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
221
|
Created
|
11/15/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |